Innovations & Research

New Orleans shows the signs of a city reborn from the destruction brought on by Hurricane Katrina.  The changes in the city’s infrastructure and building projects have certainly been among them.  The city reached a  milestone its renaissance when the New Orleans BioInnovation Center (NOBIC) opened for business.

The Small Business Innovation Research Grants Program Provides Critical Support to Small Biotech Companies Working on Promising Innovations

There are many reasons to be excited about financing early stage biotech companies. The BIO Investor Forum will assemble the most promising among promising discovery stage companies. 

This week’s BIO China International Conference displayed a growing recognition of China’s emergence as a global leader in the biotech industry and discussions focused on how to navigate the opportunities and challenges that exist in the rapidly emerging market.

During this period of tremendous growth in both the Indian economy and its healthcare sector, it is a critical time to capitalize on the biotech opportunities available within India.

Genetic engineering of agricultural animals could be one of the most interesting and promising fields of biotechnology.

On July 26, Agriculture Secretary Tom Vilsack announced four new project areas for the Biomass Crop Assistance Program.

Society has tapped just a small fraction of the many potential uses and benefits of biotechnology.

GlycoMimetics’ Rachel King discusses the prevalence of sickle cell disease and urgency to find treatments.

Biofuels Digest and BIO have launched the Summer 2011 Bioenergy Business Outlook Survey.

BIOtechNOW’s Tracy Cooley talks to Dr. Reed from the   Sanford-Burnham Medical Institute about the NIH’s new National Center for Advancing Translational Sciences.

Some of the most pressing challenges for the advent of personalized medicine relate to the reimbursement of novel diagnostics. Reimbursement policies must reflect the potential benefit that novel diagnostics can bring to patients and the healthcare system. This value proposition can be realized through reimbursement policy reforms that provide a clear and consistent pathway to obtain affirmative coverage, appropriate and timely coding, and market-based payment for diagnostic tests. BIO recommends that the following reforms be made to diagnostic reimbursement policy.

The federal Renewable Fuel Standard provides the stable policy essential to attracting private investment to the development of advanced biofuels. The Biotechnology Industry Organization (BIO) today joined the Advanced BioFuel Association, the Renewable Fuel Association, the Advanced Ethanol Council and the American Coalition for Ethanol in a letter to leaders of the House Committee on Energy and Commerce and the Senate Committee on Environment and Public Works urging protection of the federal RFS.

The Biotechnology Industry Organization (BIO) today thanked Agriculture Secretary Tom Vilsack and Energy Secretary Steven Chu on the announcement of Biomass Research And Development Initiative grants and the establishment of a Biomass Crop Assistance Plan project area. BIO congratulated member companies Cellana LLC of Hawaii and Metabolix Inc. of Massachusetts on receiving awarded grants.

Letters, Testimony & Comments

December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of...
July 28 2011
The Biotechnology Industry Organization (BIO) is the world's largest biotechnology organization, providing advocacy, business...
January 11 2011
January 7, 2011 President's Council of Advisors on Science and Technology (PCAST) Public Oral Comments Ladies and Gentlemen:...
May 27 2009
Re: Draft National Institutes of Health Guidelines for Human Stem Cell Research (FR Doc. E9-9313) Dear Sir/Madam: The Biotechnology...
June 6 2007
BIO Letter to Speaker Pelosi regard BIO's support for S. 5

Press Releases

March 22 2012
  Washington, DC (March 22, 2012) – The Biotechnology Industry Organization (BIO) applauds the Senate...
September 16 2011
Washington, D.C. (September 16, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim...
September 1 2011
WASHINGTON, D.C.(Sept. 1, 2011) – Research and development in synthetic biology is an evolution of...
June 29 2011
WASHINGTON, D.C. (Wednesday, June 29, 2011) - The Biotechnology Industry Organization (BIO) released today a summary...
June 16 2011
WASHINGTON, D.C. (Thursday, June 16, 2011) - The 2011 Translational Research Forum, hosted by the Biotechnology...